Market Research Report
The U.S. Market for Biodefense-Related Rapid Pathogen Identification and Treatments
|Published by||BCC Research||Product code||337317|
|Published||Content info||144 Pages
Delivery time: 1-2 business days
|The U.S. Market for Biodefense-Related Rapid Pathogen Identification and Treatments|
|Published: August 13, 2015||Content info: 144 Pages||
The projected U.S. market for biodefense-related rapid pathogen detection devices is valued at $214.2 million in 2015. The total market is projected to grow at a compound annual growth rate (CAGR) of 8% from 2016 through 2021 and reach $248 million by 2016 and $364 million by 2021.
The market report organizes information from diverse sources into a cohesive unit that includes an industry overview; overview of infectious agents with detection, vaccine and treatment information; biodefense-related diagnostic tools; current research and emerging industries related to rapid pathogen identification; biodefense-related pathogen identification product patents; and a comprehensive directory of assay, sensor, vaccine and treatment companies.
Peggy S. Lehr is the BCC Research analyst of this report. Ms. Lehr holds a BS in Journalism from the University of Colorado, Boulder and an MS in Communication from the University of Denver. Ms. Lehr has worked within the publishing industry for both for-profit and not-for-profit organizations, and she has specialized in marketing reports on the medical industry for 20 years.